Home›Companies›Healthcare›TriAgenics

TriAgenics, Inc

Updated Oct 27, 2026·Latest SEC filing Apr 17, 2025·Suggest an edit

About TriAgenics

TriAgenics is a private company based in Redmond, Oregon. It has reported $3,812,302 raised in three offerings on Form D since March 2018. Its chief executive is David Thrower.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 11, 2025Apr 17, 2025$500,000of $3.0M target1$500KEquityRule 506(b)Form D ↗
Dec 15, 2020Aug 5, 2020amended Sep 2, 2021$1,912,302of $2.5M target27$70,826EquityRule 504Form D/A ↗1 earlier filing
Feb 23, 2018Mar 8, 2018$1,400,000of $1.5M target1$1.4MEquityRule 506(b)Form D ↗
Total, three offerings$3,812,302

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TriAgenics's Form D filed Apr 17, 2025.

JC
John Chopack
Director
DT
David Thrower
Chief Executive Officer and director
JJ
GS
DW
David Waston
Director
LC
Leigh Colby
Executive officer and director

Earlier filings also listed Walter Diers (executive officer and director, last listed Sep 2021), David Watson (executive officer and director, last listed Sep 2021) and Mike Diers (promoter, last listed Mar 2018).

Sources

  1. SECTriAgenics, Inc Form D, filed Aug 5, 2020
  2. SECTriAgenics, Inc filing history